XML 39 R1.htm IDEA: XBRL DOCUMENT v3.24.1
Document and Entity Information - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Mar. 20, 2024
Jun. 30, 2023
Cover [Abstract]      
Document Type 10-K    
Amendment Flag false    
Document Period End Date Dec. 31, 2023    
Document Fiscal Year Focus 2023    
Document Fiscal Period Focus FY    
Document Transition Report false    
Document Annual Report true    
Entity Registrant Name Pyxis Oncology, Inc.    
Entity Central Index Key 0001782223    
Current Fiscal Year End Date --12-31    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company true    
Entity Ex Transition Period true    
ICFR Auditor Attestation Flag false    
Entity Shell Company false    
Entity Well-known Seasoned Issuer No    
Document Financial Statement Error Correction [Flag] false    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity File Number 001-40881    
Entity Tax Identification Number 83-1160910    
Entity Address, Address Line One 321 Harrison Avenue    
Entity Address, City or Town Boston    
Entity Address, State or Province MA    
Entity Address, Postal Zip Code 02118    
Entity Incorporation, State or Country Code DE    
City Area Code 617    
Local Phone Number 221-9059    
Title of 12(b) Security Common Stock, par value $0.001 per share    
Trading Symbol PYXS    
Security Exchange Name NASDAQ    
Entity Public Float     $ 97.0
Entity Common Stock, Shares Outstanding   58,133,375  
Auditor Name Ernst & Young LLP    
Auditor Firm ID 42    
Auditor Location Boston, Massachusetts    
Documents Incorporated by Reference

DOCUMENTS INCORPORATED BY REFERENCE

None.